DHA Shifts Acquisition Toward Warfighter Readiness and Measurable Results

Defense Health Agency (DHA) acquisition leader retired Army Col. Matthew Clark is beginning a transition focused on making research, development, acquisition, and contracting more directly support warfighter readiness and military healthcare services. DHA announced Clark’s appointment as assistant director for its research, development, and acquisition enterprise in a Nov. 3, 2026, story. Sworn in by DHA Director Navy Vice Adm. Darin K. Via on Sept. 21 at Defense Health Headquarters in Falls Church, Virginia, Clark serves as both the component acquisition executive and senior procurement executive. His 30-60-90-day DELIVER Care plan is intended to bring the enterprise’s activities into closer alignment with mission needs, measurable outcomes, and faster delivery.

Clark’s experience spans more than 30 years in military operations, medical product development, public health, and national security. Before retiring from the U.S. Army in August 2026, he commanded the SHAPE Healthcare Facility and U.S. Army Health Clinic Brussels in Belgium. In describing his approach, Clark said the team will examine “what the force needs, when it needs it, and how their work supports that need,” while placing qualified personnel and resources behind DHA’s highest priorities. He also emphasized that “the job is about delivering results and delivering support.” Those statements frame the transition as an operational and acquisition-management effort: programs and portfolios are expected to demonstrate a clear connection between spending, delivery, and healthcare or readiness outcomes.

For contractors, the immediate signal is increased scrutiny rather than a newly released competition. DHA plans closer portfolio review, which could result in winding down work considered low-value. Incumbents and prospective suppliers should be prepared to explain the mission contribution of their work, identify measurable results, and show how delivery timelines respond to operational needs. The source material does not identify a specific target for reductions, provide evaluation criteria, or state that any contract has been terminated. Companies should therefore treat the portfolio-review signal as an indication of management priorities—not as confirmation of a particular acquisition decision.

Two areas are identified as procurement interests: a commercial-solutions effort for the Data Exchange Platform and a research-support multiple-award IDIQ. These references may help vendors monitor DHA’s future acquisition activity and assess whether commercial capabilities or research support align with the DELIVER Care priorities. However, the available information provides no solicitation number, contract value, procurement deadline, or award announcement for either effort. Companies should avoid assuming that a formal solicitation is imminent and should monitor official DHA notices for requirements, schedules, and competition details. The practical near-term response is to map offerings to mission outcomes, prepare evidence of performance and measurable impact, and track public procurement channels for further information.

• Matthew Clark is DHA’s assistant director for the research, development, and acquisition enterprise, component acquisition executive, and senior procurement executive.
• Clark was sworn in by DHA Director Navy Vice Adm. Darin K. Via on Sept. 21 at Defense Health Headquarters in Falls Church, Virginia.
• The 30-60-90-day DELIVER Care transition plan seeks closer alignment among research, acquisition, contracting, warfighter readiness, measurable outcomes, and faster delivery.
• DHA’s portfolio scrutiny may lead to winding down work viewed as low-value; contractors should be ready to substantiate mission relevance and results.
• The Data Exchange Platform commercial-solutions effort is identified as an area of procurement interest, but no solicitation number, value, or response timeline is provided.
• A research-support multiple-award IDIQ is also identified as an area of interest; the source does not announce an award or provide competition details.
• Clark brings more than 30 years of experience in military operations, medical product development, public health, and national security.
• Clark retired from the U.S. Army in August 2026 after serving as commander of the SHAPE Healthcare Facility and U.S. Army Health Clinic Brussels.
• Contractors across DHA portfolios can assess how their offerings support mission needs, demonstrate measurable outcomes, and enable faster delivery while monitoring official notices for procurement updates.